Latest News about MNTA
Recent news which mentions MNTA
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
From Motley Fool
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
October 01, 2020
From Benzinga
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
September 30, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
September 29, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut
September 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
September 28, 2020
From Benzinga
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
From Benzinga
3 Stocks to Help You Build Retirement Wealth
September 26, 2020
From Motley Fool
The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO
September 16, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
September 15, 2020
From Benzinga
3 Dividend Stocks I'd Buy Right Now
September 12, 2020
From Motley Fool
Plasma-Centric Drugmaker Grifols To Buy Geriatric Pharma Startup Alkahest
September 08, 2020
From Benzinga
2 Top Coronavirus Vaccine Stocks to Buy When the Next Market Crash Comes
September 04, 2020
From Motley Fool
Surge in megadeals points to M&A recovery as tech sector dominates
September 01, 2020
From MarketWatch
3 Stocks to Buy and Hold for Decades
August 30, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For August 25, 2020
August 25, 2020
From Benzinga
Johnson & Johnson Borrows $7.5B To Fund Its Purchase Of Momenta
August 20, 2020
From Benzinga
From MarketWatch
Benzinga's Top Upgrades, Downgrades For August 20, 2020
August 20, 2020
From Benzinga
10 Biggest Price Target Changes For Thursday
August 20, 2020
From Benzinga
The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics
August 20, 2020
From Benzinga
68 Biggest Movers From Yesterday
August 20, 2020
From Benzinga
From Motley Fool
Why Immunovant Could Benefit From The J&J-Momenta Deal
August 19, 2020
From Benzinga
Mid-Afternoon Market Update: Momenta Pharmaceuticals Jumps Following Acquisition News; Galapagos Shares Slide
August 19, 2020
From Benzinga
Why Momenta Pharmaceuticals Stock Rocketed 69% Higher Today
August 19, 2020
From Motley Fool
From Motley Fool
54 Stocks Moving In Wednesday's Mid-Day Session
August 19, 2020
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.